When patients’ lives are at the center of what you do, experience matters

We have the relationships, knowledge and experience you need to successfully develop and deliver your cellular therapy.

About Us

Discovery

Customizable research and cell sourcing solutions

Preclinical and Clinical

Solutions to help bring your cellular therapy from preclinical development through to commercialization

Commercial

Your cell supply chain and cell sourcing solutions

For 30 years, our parent company, the National Marrow Donor Program® (NMDP)/Be The Match®, has matched donors and patients, and used personalized end-to-end case management to facilitate the collection, tracking and delivery of cells around the world.

We’re extending these proven solutions to organizations developing and delivering new autologous and allogeneic cellular therapies to patients. Whether your cellular therapy is in discovery, clinical trials or ready for commercialization, we offer customizable solutions to meet your needs.

Cell Lines Blog →

Emerging areas: Geckos, monkeys and mice, oh my

New studies suggest cell and gene therapy holds the key to treating spinal injuries

In-the-News: March 2018

Q&A With Be The Match BioTherapies Medical Director, Dr. Steven Devine

Part 2

Q&A With Be The Match BioTherapies Medical Director, Dr. Steven Devine

Part 1

Emerging research: Can stem cell treatments help patients with heart failure?

Continue Reading

19

million people in world’s largest registry

80,000

cellular transplants facilitated worldwide over the past 30 years

22,000

cell and blood shipments managed annually around the world

“If the services and expertise we’ve built over the course of our history can help patients in new ways, we feel it’s our obligation to help.”

— Jeffrey Chell, M.D., CEO Emeritus, NMDP/Be The Match and Be The Match BioTherapies®